The Food and Drug Administration (FDA) has granted approval for Eli Lilly's highly anticipated obesity treatment, marking a significant development in the pharmaceutical industry. As experts predict, this breakthrough medicine is expected to become one of the highest-grossing drugs in history. Zepbound: An Obesity Treatment with a Promising Future Previously known as Mounjaro … [Read more...] about A Game-Changer in Obesity Treatment: The FDA Approves Eli Lilly’s Zepbound
FDA
FDA Addresses Concerns about Tornado’s Impact on Pfizer Plant
The Food and Drug Administration (FDA) has moved swiftly to alleviate concerns over potential drug shortages following the tornado strike on a Pfizer plant in North Carolina. Assuring the public, the FDA stated that there are currently ample supplies of drugs in hospitals and the distribution system to prevent a crisis. Contrary to initial reports that the plant supplied 25% of … [Read more...] about FDA Addresses Concerns about Tornado’s Impact on Pfizer Plant
First Long-Acting Drug Approved by FDA to Protect Infants and Toddlers from Respiratory Virus
The United States officials have granted approval for the first long-acting drug that offers protection against a respiratory virus that poses a significant threat to babies and toddlers, sending a large number of American children to the hospital every year. Respiratory Syncytial Virus (RSV) is typically a minor inconvenience for most healthy individuals, resembling a common … [Read more...] about First Long-Acting Drug Approved by FDA to Protect Infants and Toddlers from Respiratory Virus
